Greenwashing

ES EN

Glenmark Pharma reports revenue growth of 22 . 5 per cent , EBITDA growth of 46 . 2 per cent YoY for Q1 FY 2023 - 24

Source: aninews.in
Published on 2023-08-12

« Good governance is a bad idea
Fourth Partner Energy gets additional Rs 350 cr equity from Norfund  »